Claudin-1-Targeted Nanoparticles for Delivery to Aging-Induced Alterations in the Blood–Brain Barrier
Open accessAbstract
Aging-induced alterations to the blood–brain barrier (BBB) are increasingly being seen as a primary event in chronic progressive neurological disorders that lead to cognitive decline. With the goal of increasing delivery into the brain in hopes of effectively treating these diseases, a large focus has been placed on developing BBB permeable materials. However, these strategies have suffered from a lack of specificity toward regions of disease progression. Here, we report on the development of a nanoparticle (C1C2-NP) that targets regions of increased claudin-1 expression that reduces BBB integrity. Using dynamic contrast enhanced magnetic resonance imaging, we find that C1C2-NP accumulation and retention is significantly increased in brains from 12 month-old mice as compared to nontargeted NPs and brains from 2 month-old mice. Furthermore, we find C1C2-NP accumulation in brain endothelial cells with high claudin-1 expression, suggesting target-specific binding of the NPs, which was validated through fluorescence imaging, in vitro testing, and biophysical analyses. Our results further suggest a role of claudin-1 in reducing BBB integrity during aging and show altered expression of claudin-1 can be actively targeted with NPs. These findings could help develop strategies for longitudinal monitoring of tight junction protein expression changes during aging as well as be used as a delivery strategy for site-specific delivery of therapeutics at these early stages of disease development.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The expression and functionality of tight junction proteins between endothelial cells, such as occludin and claudin, are reduced with ageing.
“The expression and functionality of proteins that form tight junctions between endothelial cells, such as occludin and claudin, are reduced.151,152”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Montagne, A., Nikolakopoulou, A. M., Zhao, Z., Sagare, A. P., Si, G., Lazic, D., Barnes, S. R., Daianu, M., Ramanathan, A., Go, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4482 · Cited by 344 · see citing works
RetractedStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185 · see citing works
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, D. B., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,887 · see citing works
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523 · see citing works
Chithrani, D. B., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,274 · see citing works
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102 · see citing works
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,054 · see citing works
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0297-y · Cited by 1,728 · see citing works
Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton
Hartsock, A., & Nelson, W. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.07.012 · Cited by 1,559 · see citing works
Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing
Cabeza, R., Albert, M., Belleville, S., Craik, F. I. M., Duarte, A., Grady, C. L., Lindenberger, U., Nyberg, L., Park, D. C., Reuter-Lorenz, P. A., et al. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0068-2 · Cited by 1,289 · see citing works
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190 · see citing works
Tight junctions of the blood-brain barrier: development, composition and regulation.
Wolburg, H., & Lippoldt, A. (2002) · PubMed · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,184 · see citing works
Ageing, neurodegeneration and brain rejuvenation
Wyss-Coray, T. (2016) · Nature · doi:10.1038/nature20411 · Cited by 1,147 · see citing works
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060 · see citing works
Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
Farrall, A. J., & Wardlaw, J. M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.015 · Cited by 882 · see citing works
Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH
Zhang, G., Li, J., Purkayastha, S., Tang, Y., Zhang, H., Yin, Y., Li, B., Liu, G., & Cai, D. (2013) · Nature · doi:10.1038/nature12143 · Cited by 834 · see citing works
Wnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 793 · see citing works
Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands
Furuse, M., Sasaki, H., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.4.891 · Cited by 746 · see citing works
Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state
Deoni, S., Rutt, B. K., & Peters, T. M. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10407 · Cited by 745 · see citing works
The mitochondrial‐lysosomal axis theory of aging
Brunk, U. T., & Terman, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02869.x · Cited by 729 · see citing works
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 646 · see citing works
Blood brain barrier: ageing and microvascular disease-systematic review and meta-analysis
Farrall, A., & Wardlaw, J. M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.089 · Cited by 639 · see citing works
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 569 · see citing works
Restoring metabolism of myeloid cells reverses cognitive decline in ageing
Minhas, P. S., Latif-Hernandez, A., McReynolds, M. R., Durairaj, A. S., Wang, Q., Rubin, A., Joshi, A. U., He, J. Q., Gauba, E., Liu, L., et al. (2021) · Nature · doi:10.1038/s41586-020-03160-0 · Cited by 526 · see citing works
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · see citing works
Microvascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487 · see citing works
Hasegawa, K., Wakino, S., Šimić, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., et al. (2013) · Nature Medicine · doi:10.1038/nm.3363 · Cited by 485 · see citing works
Deoni, S., Peters, T. M., & Rutt, B. K. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20314 · Cited by 482 · see citing works
Liang, W. S., Dunckley, T. L., Beach, T. G., Grover, A., Mastroeni, D., Walker, D. G., Caselli, R. J., Kukull, W. A., McKeel, D. W., Morris, J. C., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00208.2006 · Cited by 342 · see citing works
Mullier, A., Bouret, S. G., Prevot, V., & Dehouck, B. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22273 · Cited by 334 · see citing works
Kumagai, A. K., Eisenberg, J., & Pardridge, W. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48160-4 · Cited by 325 · see citing works
Elahy, M., Jackaman, C., Mamo, J. C., Lam, V., Dhaliwal, S. S., Giles, C., Nelson, D., & Takechi, R. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0029-9 · Cited by 300 · see citing works
Clark, R. S. B., Schiding, J. K., Kaczorowski, S. L., Marion, D. W., & Kochanek, P. M. (1994) · Journal of Neurotrauma · doi:10.1089/neu.1994.11.499 · Cited by 291 · see citing works
Thioalkylated tetraethylene glycol: a new ligand for water soluble monolayer protected gold clusters
Kanaras, A. G., Kamounah, F. S., Schaumburg, K., Kiely, C. J., & Brust, M. (2002) · Chemical Communications · doi:10.1039/b207838b · Cited by 256 · see citing works
Synthesis and characterisation of Gd2O3 nanocrystals functionalised by organic acids
Söderlind, F., Pedersen, H., Petoral, R. M., Käll, P., & Uvdal, K. (2005) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2005.02.089 · Cited by 251 · see citing works
Feng, S., Cen, J., Huang, Y., Shen, H., Li, Y., Wang, Y., & Chen, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020599 · Cited by 236 · see citing works
Hug, S. J., & Bahnemann, D. W. (2005) · Journal of Electron Spectroscopy and Related Phenomena · doi:10.1016/j.elspec.2005.05.006 · Cited by 231 · see citing works
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Horng, S., Therattil, A., Moyon, S., Gordon, A., Kim, K., Argaw, A. T., Hara, Y., Mariani, J. N., Sawai, S., Flodby, P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91301 · Cited by 221 · see citing works
Tran, K. A., Zhang, X., Predescu, D., Huang, X., Machado, R. F., Göthert, J. R., Malik, A. B., Valyi-Nagy, T., & Zhao, Y.-Y. (2016) · Circulation · doi:10.1161/circulationaha.115.015982 · Cited by 219 · see citing works
Georgieva, J. V., Kalicharan, D., Couraud, P., Romero, I. A., Weksler, B. B., Hoekstra, D., & Zuhorn, I. S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.236 · Cited by 211 · see citing works
Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions
Erickson, M. A., & Banks, W. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071632 · Cited by 192 · see citing works
Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability
Heye, A. K., Thrippleton, M. J., Armitage, P. A., Valdés Hernández, M. D. C., Makin, S. D., Glatz, A., Sakka, E., & Wardlaw, J. M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.018 · Cited by 187 · see citing works
Structural organization of the tight junctions
Paris, L., Tonutti, L., Vannini, C., & Bazzoni, G. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.004 · Cited by 171 · see citing works
Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response
Li, Z., Sun, L., Zhang, Y., Dove, A. P., O’Reilly, R. K., & Chen, G. (2016) · ACS Macro Letters · doi:10.1021/acsmacrolett.6b00419 · Cited by 165 · see citing works
Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160 · see citing works
Claudin Heterogeneity and Control of Lung Tight Junctions
Koval, M. H. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183809 · Cited by 155 · see citing works
Yu, A. S. L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030284 · Cited by 151 · see citing works
Stamatovic, S. M., Martínez-Revollar, G., Hu, A., Choi, J. H. K., Keep, R. F., & Andjelkovic, A. V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.006 · Cited by 149 · see citing works
Immunolocalization of tight junction proteins in the adult and developing human brain
Virgintino, D., Errede, M., Robertson, D. M., Capobianco, C., Girolamo, F., Vimercati, A., Bertossi, M., & Roncali, L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0665-1 · Cited by 145 · see citing works
Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke
Sladojević, N., Stamatovic, S. M., Johnson, A., Choi, J. H. K., Hu, A., Dithmer, S., Blasig, I. E., Keep, R. F., & Andjelkovic, A. V. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1432-18.2018 · Cited by 142 · see citing works
Wu, L., Ahmadvand, D., Su, J., Hall, A., Tan, X., Farhangrazi, Z. S., & Moghimi, S. M. (2019) · Nature Communications · doi:10.1038/s41467-019-12554-2 · Cited by 140 · see citing works
Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex
Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137 · see citing works
Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries
Kwon, E. J., Skalak, M., Bu, R. L., & Bhatia, S. N. (2016) · ACS Nano · doi:10.1021/acsnano.6b03858 · Cited by 134 · see citing works
Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia
Chen, T., Dai, S., Li, X., Luo, P., Zhu, J., Wang, Y., Fei, Z., & Jiang, X. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.016 · Cited by 134 · see citing works
Gonzalez-Carter, D., Liu, X., Tockary, T. A., Dirisala, A., Toh, K., Anraku, Y., & Kataoka, K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002016117 · Cited by 127 · see citing works
A Key Claudin Extracellular Loop Domain is Critical for Epithelial Barrier Integrity
Mrsny, R. J., Brown, G. T., Gerner-Smidt, K., Buret, A. G., Meddings, J. B., Quan, C. L., Koval, M. H., & Nusrat, A. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070698 · Cited by 124 · see citing works
Chung, N. P. Y., Mruk, D. D., Mo, M., Lee, W. M., & Cheng, C. Y. (2001) · Biology of Reproduction · doi:10.1095/biolreprod65.5.1340 · Cited by 121 · see citing works
Barnes, S. R., Ng, T. S. C., Montagne, A., Law, M., Zlokovic, B. V., & Jacobs, R. E. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25793 · Cited by 115 · see citing works
Neves, A. R., Queiroz, J. F., Lima, S. A. C., & Reis, S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00705 · Cited by 113 · see citing works
Uchida, Y., Sumiya, T., Tachikawa, M., Yamakawa, T., Murata, S., Yagi, Y., Sato, K., Stephan, A., Ito, K., Ohtsuki, S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1207-5 · Cited by 97 · see citing works
Yoo, D., Magsam, A. W., Kelly, A. M., Stayton, P., Kievit, F., & Convertine, A. J. (2017) · ACS Nano · doi:10.1021/acsnano.7b03426 · Cited by 94 · see citing works
Self-citationBharadwaj, V. N., Lifshitz, J., Adelson, P. D., Kodibagkar, V. D., & Stabenfeldt, S. E. (2016) · Scientific Reports · doi:10.1038/srep29988 · Cited by 93 · see citing works
Yuan, H., & Zhang, S. (2010) · Applied Physics Letters · doi:10.1063/1.3293303 · Cited by 90 · see citing works
Who watches the watchmen? Regulation of the expression and activity of sirtuins
Buler, M., Andersson, U., & Hakkola, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600410rr · Cited by 84 · see citing works
The blood-brain barrier choline transporter as a brain drug delivery vector
Allen, D. D., & Lockman, P. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00504-6 · Cited by 83 · see citing works
Zhao, H., Bao, X.-J., Wang, R.-Z., Li, G.-L., Gao, J., Ma, S.-H., Wei, J.-J., Feng, M., Zhao, Y.-J., Ma, W.-B., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2010.111 · Cited by 73 · see citing works
Boyd, B. J., Galle, A., Daglas, M., Rosenfeld, J. V., & Medcalf, R. L. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1034280 · Cited by 71 · see citing works
Staat, C., Coisne, C., Dabrowski, S., Stamatovic, S. M., Andjelkovic, A. V., Wolburg, H., Engelhardt, B., & Blasig, I. E. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.007 · Cited by 66 · see citing works
Hattori, Y., Okamoto, Y., Maki, T., Yamamoto, Y., Oishi, N., Yamahara, K., Nagatsuka, K., Takahashi, R., Kalaria, R. N., Fukuyama, H., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006265 · Cited by 63 · see citing works
Claudin-9 structures reveal mechanism for toxin-induced gut barrier breakdown
Vecchio, A. J., & Stroud, R. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908929116 · Cited by 63 · see citing works
Self-citationAge-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1)
Mooradian, A. D. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00041-6 · Cited by 57 · see citing works
Theranostic Oxygen Reactive Polymers for Treatment of Traumatic Brain Injury
Xu, J. M., Ypma, M., Chiarelli, P. A., Park, J. C., Ellenbogen, R. G., Stayton, P. S., Mourad, P. D., Lee, D., Convertine, A. J., & Kievit, F. M. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504416 · Cited by 54 · see citing works
Self-citationSex-Dependent Macromolecule and Nanoparticle Delivery in Experimental Brain Injury
Bharadwaj, V. N., Copeland, C., Mathew, E., Newbern, J. M., Anderson, T. R., Lifshitz, J., Kodibagkar, V. D., & Stabenfeldt, S. E. (2020) · Tissue Engineering Part A · doi:10.1089/ten.tea.2020.0040 · Cited by 50 · see citing works
Age-Related Changes of Claudin Expression in Mouse Liver, Kidney, and Pancreas
D’Souza, T., Sherman‐Baust, C. A., Poosala, S., Mullin, J. M., & Morin, P. J. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp118 · Cited by 48 · see citing works
A Role for Nanoparticles in Treating Traumatic Brain Injury
Bony, B. A., & Kievit, F. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090473 · Cited by 43 · see citing works
Self-citationBaumholtz, A. I., Simard, A., Nikolopoulou, E., Oosenbrug, M., Collins, M. M., Piontek, A., Krause, G., Piontek, J., Greene, N. D. E., & Ryan, A. K. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.05.013 · Cited by 34 · see citing works
Blood–brainbarrier disruption dictates nanoparticle accumulation following experimental brain injury
Bharadwaj, V. N., Rowe, R. K., Harrison, J., Wu, C., Anderson, T. R., Lifshitz, J., Adelson, P., Kodibagkar, V., & Stabenfeldt, S. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.06.004 · Cited by 34 · see citing works
Bony, B. A., Miller, H. A., Tarudji, A. W., Gee, C. C., Sarella, A., Nichols, M. G., & Kievit, F. M. (2020) · ACS Omega · doi:10.1021/acsomega.0c01890 · Cited by 30 · see citing works
Self-citationMiller, H. A., Magsam, A. W., Tarudji, A. W., Romanova, S., Weber, L., Gee, C. C., Madsen, G. L., Bronich, T. K., & Kievit, F. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-52622-7 · Cited by 29 · see citing works
Self-citationAn Activity-Based Nanosensor for Traumatic Brain Injury
Kudryashev, J. A., Waggoner, L. E., Leng, H. T., Mininni, N. H., & Kwon, E. J. (2020) · ACS Sensors · doi:10.1021/acssensors.9b01812 · Cited by 28 · see citing works
Neuroimaging of cerebrovascular disease in the aging brain.
Gupta, A. K., Nair, S., Schweitzer, A. D., et al. (2012) · PubMed · Cited by 26 · see citing works
Gene delivery to brain cells with apoprotein E derived peptide conjugated to polylysine (apoEdp-PLL)
Mousazadeh, M. H., Palizban, A., Salehi, R., & Salehi, M. (2007) · Journal of drug targeting · doi:10.1080/10611860601148908 · Cited by 23 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Andjelkovic, A. V., Situ, M., Citalán‐Madrid, A. F., Stamatovic, S. M., Xiang, J., & Keep, R. F. (2023) · Stroke · doi:10.1161/strokeaha.122.040578 · Cited by 175 · see citing works
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165 · see citing works
“151,152 The structure and function of the BBB also undergo signi fi cant alterations with ageing, which contribute to the progression of neurodegenerative diseases and cognitive decline.”
Asimakidou, E., Tan, J. K. S., Zeng, J., & Lo, C. H. (2024) · Pharmaceuticals · doi:10.3390/ph17050612 · Cited by 115 · see citing works
Wu, J., Zhu, Z., Liu, W., Zhang, Y., Kang, Y., Liu, J., Hu, C., Wang, R., Zhang, M., Chen, L., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05317 · Cited by 109 · see citing works
Targeting endothelial permeability in the EPR effect
Lahooti, B., Akwii, R. G., Zahra, F. T., Sajib, M. S., Λάμπρου, Μ., Alobaida, A., Lionakis, M. S., Mattheolabakis, G., & Mikelis, C. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.039 · Cited by 106 · see citing works
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
Wu, J. R., Hernández, Y. M., Miyasaki, K. F., & Kwon, E. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114820 · Cited by 103 · see citing works
Blood-brain barrier disruption: a culprit of cognitive decline?
Che, J., Sun, Y., Deng, Y., & Zhang, J. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00563-3 · Cited by 103 · see citing works
The blood–brain barrier: a help and a hindrance
Rust, R., Yin, H. R., Buil, B. A., Sagare, A. P., & Kisler, K. (2025) · Brain · doi:10.1093/brain/awaf068 · Cited by 102 · see citing works
“126 Also, the function of systems regulating the circulation of brain extracellular fluid and CSF are decreased with healthy ageing.”
Markowicz-Piasecka, M., Markiewicz, A., Darłak, P., Sikora, J., Adla, S. K., Bagina, S., & Huttunen, K. M. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01228-5 · Cited by 68 · see citing works
“β1-integrin-mediated adhesion of brain ECs to the ECM is critical for stabilizing claudin-5 in BBB tight junctions (TJs) and BBB integrity [9, 260].”
BackgroundInterfacing with the Brain: How Nanotechnology Can Contribute
Ahmed, A. A. A., Alegret, N., Almeida, B., Álvarez‐Puebla, R. A., Andrews, A. M., Ballerini, L., Barrios‐Capuchino, J. J., Becker, C., Blick, R. H., Bonakdar, S., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c10525 · Cited by 68 · see citing works
Self-citationPrecision targeting of the CNS: recent progress in brain-directed nanodrug delivery
Senanayake, D., Yapa, P. N., Dabare, S., & Munaweera, I. (2025) · RSC Advances · doi:10.1039/d5ra03578c · Cited by 52 · see citing works
Ramirez-Velez, I., & Belardi, B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114905 · Cited by 45 · see citing works
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33 · see citing works
Sex-based differences of antioxidant enzyme nanoparticle effects following traumatic brain injury
Tarudji, A. W., Miller, H. A., Curtis, E. T., Porter, C. L., Madsen, G. L., & Kievit, F. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.065 · Cited by 28 · see citing works
Self-citationAdvanced nanoparticle engineering for precision therapeutics of brain diseases
Ismail, M., Liu, J., Wang, N., Zhang, D., Qin, C., Shi, B., & Zheng, M. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123138 · Cited by 23 · see citing works
Blood-brain barrier biomarkers
Zapata-Acevedo, J. F., Mantilla-Galindo, A., Vargas-Sánchez, K., & González-Reyes, R. E. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.004 · Cited by 23 · see citing works
Gowrikumar, S., Tarudji, A. W., McDonald, B. Z., Balusa, S. S., Kievit, F. M., & Dhawan, P. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2470482 · Cited by 21 · see citing works
“18,20,21 This increased presentation of CLDN1 may impair the function of CLDN5 homo or heterodimers at the BBB. 18 Nevertheless, there remains a lack of mechanistic evidence of CLDN1 overexpression at the BBB and its role in altered permeability.”
Self-citationZhao, Y., Chen, C., Xiao, X., Fang, L., Cheng, X., Chang, Y., Peng, F., Wang, J., Shen, S., Wu, S., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03655-7 · Cited by 20 · see citing works
Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier
Alonso-Alonso, M. L., Sampedro‐Viana, A., Fernández‐Rodicio, S., Bazarra‐Barreiros, M., Ouro, A., Sobrino, T., Campos, F., Castillo, J., Hervella, P., & Iglesias‐Rey, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169486 · Cited by 14 · see citing works
Yu, D., Han, N., Son, H., Kim, S. J., & Kweon, S. (2026) · Journal of Functional Biomaterials · doi:10.3390/jfb17010037 · Cited by 13 · see citing works
“The CIC2 peptide, derived from claudin-1, modulates barrier function by interacting with claudin-1 and is internalized into vesicular structures that colocalize with claudin-1 [56].”
Nano-oncology revisited: Insights on precise therapeutic advances and challenges in tumor
Teng, L., Bi, Y., Xing, X., & Yao, G. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.03.024 · Cited by 13 · see citing works
“This design strategy offers a novel approach for nanomedicine delivery systems in brain cancer therapy [ 91 ].”
Jiang, Y., Zhang, J., Ye, J., Jin, X., Zhao, Y., Xu, H., Chu, B., He, Y., & Wang, H. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c01626 · Cited by 12 · see citing works
Pericyte-glial cell interactions: Insights into brain health and disease
Sepehrinezhad, A., & Gorji, A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01472 · Cited by 11 · see citing works
“…in PDGF-B availability led to a deficiency of pericytes, a loss of AQP4 polarization, and a disruption of glymphatic function, pointing to the important role of pericyte-astrocyte interactions in maintaining glymphatic system integrity in the mouse brain (Munk et al., 2019; Bony et al., 2021).”
Schweiger, B., & Kievit, F. M. (2025) · Experimental Brain Research · doi:10.1007/s00221-025-07018-7 · Cited by 8 · see citing works
“However, claudin-1 expression within the brain has been observed in several disease states including ischemic stroke (Sladojevic et al. 2019), experimental autoimmune encephalomyelitis (Pfeiffer et al. 2011), and aging (Bony et al. 2021; Miller et al. 2024).”
Self-citationWang, D., Wang, J., Li, B., Yang, S., Guo, F., Zheng, B., & Wang, J. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01312-4 · Cited by 9 · see citing works
“Claudin-1 is a transmembrane protein and one of the main components along with other members of the claudin family, plays a role in TJs, which is crucial for maintaining BBB function (Bony et al. 2021).”
Tarudji, A. W., Gee, C. C., Miller, H. A., Steffen, R., Curtis, E. T., Priester, A. M., Convertine, A. J., & Kievit, F. M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300147 · Cited by 8 · see citing works
Self-citationMeng, W., Ma, Z., Ye, H., Liu, L., Han, Q., & Shi, Q. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02676k · Cited by 5 · see citing works
Wei, D. (2025) · American Journal of Translational Research · doi:10.62347/gggx3909 · Cited by 3 · see citing works
A review on brain-targeting nano-based drug delivery
Li, P., Chen, Y., Gao, X., & Jiang, G. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1147 · Cited by 3 · see citing works
Miller, H. A., Priester, A. M., Curtis, E. T., Hilmas, K., Abbott, A., Kievit, F. M., & Convertine, A. J. (2024) · Sensors & Diagnostics · doi:10.1039/d4sd00063c · Cited by 2 · see citing works
“Attaching Gd to larger structures can benefit contrast by slowing molecular tumbling rates, thereby decreasing diffusional and rotational correlation times.”
BackgroundMethodSelf-citationNovel Rapid In Situ Curable PEGDA/PEG Composite Hydrogel Drives Biological Closure of Aneurysm Neck
Wang, X. X., Teng, J., Cui, J., Wei, R., Zhou, S., Yan, Z., Zeng, X., Cen, W., Zhang, Z., Zhang, Y., et al. (2026) · ACS Omega · doi:10.1021/acsomega.5c09657 · Cited by 1 · see citing works
Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration
Vega-García, A., Apolinar, L. M., Feria-Romero, I. A., Campos‐Bedolla, P., Alberto, G.-G. C., Luna‐Munguía, H., Sofía, R.-H., & Orozco-Suárez, S. A. (2026) · Brain Sciences · doi:10.3390/brainsci16101019 · Cited by 1 · see citing works
“A gradual decrease in the proteins that make up TJs has been observed [211], indicating that decreased claudin-5 expression marks BBB aging and that decreased claudin-1 is associated with vascular senescence [212–214].”
Imaging Techniques to Study Tight Junctions
Ali, T. A., Akhtar, S., Nisar, S., Masoodi, T., Reddy, R. D., Bhat, A. A., & Haris, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-2415-8_4 · Cited by 1 · see citing works
Jaiswal, S., Wang, F., Wu, X., Chang, T.-S., Shirazi, A., Lee, M., Dame, M. K., Spence, J. R., & Wang, T. D. (2024) · Diagnostics · doi:10.3390/diagnostics14030273
“Also, a nanoparticle was demonstrated that specifically targets increased claudin-1 expression to reduce the blood–brain barrier integrity [37].”
BackgroundFuturistic therapeutics in pipeline for the betterment of neurodegenerative disorders
Upadhyay, H., Das, P., Sanskriti, Biswal, S., & Das, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29932-2.00014-1
Neuroinflammation: The hidden code through the Brain
Latif, M., Noreen, S., Fatima, H., Ahmad, H., & Sheikh, N. (2025) · Albus Scientia · doi:10.56512/as.2025.1.e250508
Physiological strategies for brain delivery
Gonzalez‐Carter, D. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.02.007
Wallace, J. Q., Miller, H. A., Kievit, F. M., & de Bettencourt‐Dias, A. (2026) · ACS Applied Optical Materials · doi:10.1021/acsaom.6c00062
Self-citationResearch advances in claudin-1 in the eye
Wang, L., Zhang, C. L., Li, N., Zhang, J., 刘玉龙, & Xu, G. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111132
Polymeric micelles as versatile shuttles: Strategic approaches for glioblastoma-targeted delivery
Verma, M., Kumar, A., Kanaujiya, S., Subhashchandra, G. K., Mittal, K., & Rajinikanth, P. S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108622
Delgado-Minjares, K. M., Flores-Maldonado, C., Campos-Blázquez, J. P., Díaz-Cintra, S. Y., Andrade-Guerrero, J., Colín-García, W., León‐Arcia, K., Martínez‐Fong, D., Contreras, R. G., & Soto-Rojas, L. O. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198705
“Claudin-1, although poorly studied in AD, increases in response to injury and aging and has been associated with BBB permeability [16–18].”
- Authors
- Bony, B. A., Tarudji, A. W., Miller, H. A., Gowrikumar, S., Roy, S., Curtis, E. T., Gee, C. C., Vecchio, A., Dhawan, P., & Kievit, F. M.
- Affiliations
- University of Nebraska–Lincoln (US)
- University of Nebraska Medical Center (US)
- VA Nebraska Western Iowa Health Care System (US)
- Corresponding author
- Kievit, Forrest M.
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-11-08
- Volume
- 15
- Issue
- 11
- Pages
- 18520-18531
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- PMC
- PMC9079187
- OpenAlex
- W3214241336
- Cited by
- 42
- References
- 83
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 6 · 2023: 8 · 2022: 3
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Center for Integrated Healthcare, U.S. Department of Veterans Affairs (BX002086)
- National Institute of Neurological Disorders and Stroke (R01NS109488)
- Division of Graduate Education (DGE-1610400)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- claudin-1, targeted nanoparticles, brain drug delivery, tight junction proteins, brain endothelial cells, nanoparticle accumulation, cognitive decline
- MeSH terms
- Aging, Animals, Blood-Brain Barrier, Tight Junctions, Endothelial Cells, Mice, Nanoparticles, Claudin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review